229 related articles for article (PubMed ID: 16714330)
1. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Jungert K; Buck A; Buchholz M; Wagner M; Adler G; Gress TM; Ellenrieder V
Carcinogenesis; 2006 Dec; 27(12):2392-401. PubMed ID: 16714330
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
4. FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins.
Bartholin L; Maguer-Satta V; Hayette S; Martel S; Gadoux M; Bertrand S; Corbo L; Lamadon C; Morera AM; Magaud JP; Rimokh R
Oncogene; 2001 Sep; 20(39):5409-19. PubMed ID: 11571638
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.
Johnsen SA; Subramaniam M; Janknecht R; Spelsberg TC
Oncogene; 2002 Aug; 21(37):5783-90. PubMed ID: 12173049
[TBL] [Abstract][Full Text] [Related]
6. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
[TBL] [Abstract][Full Text] [Related]
7. TGFbeta regulated gene expression by Smads and Sp1/KLF-like transcription factors in cancer.
Ellenrieder V
Anticancer Res; 2008; 28(3A):1531-9. PubMed ID: 18630508
[TBL] [Abstract][Full Text] [Related]
8. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
Halder SK; Beauchamp RD; Datta PK
Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
[TBL] [Abstract][Full Text] [Related]
9. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b.
Seoane J; Pouponnot C; Staller P; Schader M; Eilers M; Massagué J
Nat Cell Biol; 2001 Apr; 3(4):400-8. PubMed ID: 11283614
[TBL] [Abstract][Full Text] [Related]
10. The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells.
Zhu GH; Lenzi M; Schwartz EL
Oncogene; 2002 Dec; 21(55):8477-85. PubMed ID: 12466967
[TBL] [Abstract][Full Text] [Related]
11. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
12. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism.
Zhu X; Topouzis S; Liang LF; Stotish RL
Cytokine; 2004 Jun; 26(6):262-72. PubMed ID: 15183844
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
14. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
Tan R; Zhang X; Yang J; Li Y; Liu Y
J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
17. MUC5AC mucin gene regulation in pancreatic cancer cells.
Kato S; Hokari R; Crawley S; Gum J; Ahn DH; Kim JW; Kwon SW; Miura S; Basbaum CB; Kim YS
Int J Oncol; 2006 Jul; 29(1):33-40. PubMed ID: 16773182
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p53-mediated transcriptional responses by mithramycin A.
Koutsodontis G; Kardassis D
Oncogene; 2004 Dec; 23(57):9190-200. PubMed ID: 15489892
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of neuroendocrine cell type-specific expression of the chromogranin B gene: Crucial role of the transcription factors CREB, AP-2, Egr-1 and Sp1.
Mahapatra NR; Mahata M; Ghosh S; Gayen JR; O'Connor DT; Mahata SK
J Neurochem; 2006 Oct; 99(1):119-33. PubMed ID: 16987240
[TBL] [Abstract][Full Text] [Related]
20. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
Liu Y; Chen L; Ko TC; Fields AP; Thompson EA
Oncogene; 2006 Jun; 25(25):3565-75. PubMed ID: 16462766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
